Skip to content

Home Visitation Enhancing Linkages Project

Home Visitation Enhancing Linkages Project (HELP 2.0)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03750487
Acronym
HELP
Enrollment
14
Registered
2018-11-23
Start date
2020-12-01
Completion date
2022-10-31
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Brief summary

A small pilot randomized controlled trial (RCT) will be conducted to test the impact of an electronic screening and brief intervention (e-SBI) on reduction in substance use (measured via self-report), associated symptoms (depression and parenting stress), and improvement in home visiting retention and substance use treatment engagement. While a pilot RCT was originally planned, the study experienced significant delays and recruitment challenges due to the COVID-19 pandemic. Therefore, after review by the DSMB and study sponsor, the decision was made to eliminate the randomization and assign all participants to the intervention condition to evaluate feasibility and acceptability of the intervention.

Detailed description

The purpose of this clinical trial is to pilot test an electronic screening and brief intervention (e-SBI) that will be adapted for use with pregnant and postpartum women in home visiting (HV) programs. The e-SBI will be tested in a small randomized trial in two home visiting sites, with 20 home visitors and 40 clients. Home visitors will be randomized to the control intervention or the e-SBI. Clients will be surveyed at baseline, and 3- and 6- month follow-up to track e-SBI impacts on reduction in substance use (measured via self-report), associated symptoms (depression and parenting stress), and improvement in home visiting retention and substance use treatment engagement. While a pilot RCT was originally planned, the study experienced significant delays and recruitment challenges due to the COVID-19 pandemic. Therefore, after review by the DSMB and study sponsor, the decision was made to eliminate the randomization and assign all participants to the intervention condition to evaluate feasibility and acceptability of the intervention. Total enrollment was N = 14. Four participants were assigned to the control condition prior to elimination of randomization. The remaining 10 participants were assigned to the intervention condition. Primary study outcomes were feasibility and acceptability.

Interventions

BEHAVIORALe-screening & brief intervention (e-SBI)

Computer-delivered screening and brief motivational intervention targeting alcohol and drug use + goal-setting and content reinforcement

BEHAVIORALControl e-SBI

Computer-delivered screening and brief motivational intervention targeting healthy eating and exercise

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
The National Center on Addiction and Substance Abuse at Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* English-speaking, * 18 years or older, * pregnant or up to 3 months postpartum, * newly enrolling in home visiting with a participating home visitor, * not currently attending substance use treatment

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: e-SBI Session 1 Completion RateUpon completion of e-SBI session 1, approximately 2-4 weeks after enrollmente-SBI session 1 completion rate (% of participants who completed e-SBI session 1)
Acceptability: Satisfaction With e-SBI Session 1 (Intervention Group Only)Upon completion of e-SBI session 1, approximately 2-4 weeks after enrollment8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session. The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session. The following items are included in the scale: 1. How much did you like this session? 2. How easy was it to use this program? 3. How interesting was this session? 4. How respectful was this session? 5. How much were you bothered by parts of this session? (reverse scored) 6. How much did this session get you thinking about your substance use? 7. How much did you feel you were helped during this session? 8. How interested are you in working with the program again? Items were rated on a 1 to 5 Likert scale. Average across all 7 items was calculated, with item 5 reverse scored. Possible range of scores is 1 to 5. Higher scores indicate higher satisfaction with the e-SBI session.
Feasibility: e-SBI Session 2 Completion RateUpon completion of e-SBI session 2 (approximately 4-6 weeks after enrollment)e-SBI session 2 completion rate (% of participants who completed e-SBI session 2)
Acceptability: Satisfaction With e-SBI Session 2 (Intervention Group Only)Upon completion of e-SBI session 2, approximately 4-6 weeks after enrollment8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session. The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session. The following items are included in the scale: 1. How much did you like this session? 2. How easy was it to use this program? 3. How interesting was this session? 4. How respectful was this session? 5. How much were you bothered by parts of this session? (reverse scored) 6. How much did this session get you thinking about your substance use? 7. How much did you feel you were helped during this session? 8. How interested are you in working with the program again? Items were rated on a 1 to 5 Likert scale. Average across all 7 items was calculated, with item 5 reverse scored. Possible range of scores is 1 to 5. Higher scores indicate higher satisfaction with the e-SBI session.

Countries

United States

Participant flow

Participants by arm

ArmCount
E-screening & Brief Intervention (e-SBI)
A two-session (20 minutes each) computer-delivered screening and brief motivational intervention targeting alcohol and drug use. Computerized screening is conducted using the ASSIST. Session 1 of the BI includes personalized feedback, readiness to change interventions, and goal setting around substance use. Session 2 will contain motivational content reinforcing engagement in home visiting and information around other challenges mothers may experience including tobacco use, postpartum depression, and intimate partner violence. e-screening & brief intervention (e-SBI): Computer-delivered screening and brief motivational intervention targeting alcohol and drug use + goal-setting and content reinforcement
10
Control
The control group will receive a similar 2-session brief motivational intervention. Session 1 focuses on nutrition and healthy eating, session 2 focuses on exercising while pregnant or in the postpartum period. Control e-SBI: Computer-delivered screening and brief motivational intervention targeting healthy eating and exercise
4
Total14

Baseline characteristics

CharacteristicE-screening & Brief Intervention (e-SBI)TotalControl
Age, Continuous26.2 years
STANDARD_DEVIATION 4.5
27.2 years
STANDARD_DEVIATION 4.5
30.4 years
STANDARD_DEVIATION 3.4
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants9 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants5 Participants1 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants2 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants8 Participants1 Participants
Race (NIH/OMB)
White
0 Participants2 Participants2 Participants
Region of Enrollment
United States
10 Participants14 Participants4 Participants
Sex: Female, Male
Female
10 Participants14 Participants4 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 4
other
Total, other adverse events
0 / 100 / 4
serious
Total, serious adverse events
0 / 100 / 4

Outcome results

Primary

Acceptability: Satisfaction With e-SBI Session 1 (Intervention Group Only)

8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session. The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session. The following items are included in the scale: 1. How much did you like this session? 2. How easy was it to use this program? 3. How interesting was this session? 4. How respectful was this session? 5. How much were you bothered by parts of this session? (reverse scored) 6. How much did this session get you thinking about your substance use? 7. How much did you feel you were helped during this session? 8. How interested are you in working with the program again? Items were rated on a 1 to 5 Likert scale. Average across all 7 items was calculated, with item 5 reverse scored. Possible range of scores is 1 to 5. Higher scores indicate higher satisfaction with the e-SBI session.

Time frame: Upon completion of e-SBI session 1, approximately 2-4 weeks after enrollment

Population: Only 4 people completed the acceptability scale following e-SBI session 1

ArmMeasureValue (MEAN)Dispersion
E-screening & Brief Intervention (e-SBI)Acceptability: Satisfaction With e-SBI Session 1 (Intervention Group Only)4.03 units on a scaleStandard Deviation 0.45
Primary

Acceptability: Satisfaction With e-SBI Session 2 (Intervention Group Only)

8-item user satisfaction survey based on the Technology Acceptance Model completed after each e-SBI session. The scale was developed by Ondersma in prior studies of the e-SBI, it does not have a formal title. The scale measures satisfaction with the e-SBI session. The following items are included in the scale: 1. How much did you like this session? 2. How easy was it to use this program? 3. How interesting was this session? 4. How respectful was this session? 5. How much were you bothered by parts of this session? (reverse scored) 6. How much did this session get you thinking about your substance use? 7. How much did you feel you were helped during this session? 8. How interested are you in working with the program again? Items were rated on a 1 to 5 Likert scale. Average across all 7 items was calculated, with item 5 reverse scored. Possible range of scores is 1 to 5. Higher scores indicate higher satisfaction with the e-SBI session.

Time frame: Upon completion of e-SBI session 2, approximately 4-6 weeks after enrollment

Population: 7 people completed the acceptability scale following e-SBI session 2

ArmMeasureValue (MEAN)Dispersion
E-screening & Brief Intervention (e-SBI)Acceptability: Satisfaction With e-SBI Session 2 (Intervention Group Only)3.93 units on a scaleStandard Deviation 0.31
Primary

Feasibility: e-SBI Session 1 Completion Rate

e-SBI session 1 completion rate (% of participants who completed e-SBI session 1)

Time frame: Upon completion of e-SBI session 1, approximately 2-4 weeks after enrollment

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
E-screening & Brief Intervention (e-SBI)Feasibility: e-SBI Session 1 Completion RateCompleted e-SBI session 18 Participants
E-screening & Brief Intervention (e-SBI)Feasibility: e-SBI Session 1 Completion RateDid not complete e-SBI session 12 Participants
ControlFeasibility: e-SBI Session 1 Completion RateCompleted e-SBI session 14 Participants
ControlFeasibility: e-SBI Session 1 Completion RateDid not complete e-SBI session 10 Participants
Primary

Feasibility: e-SBI Session 2 Completion Rate

e-SBI session 2 completion rate (% of participants who completed e-SBI session 2)

Time frame: Upon completion of e-SBI session 2 (approximately 4-6 weeks after enrollment)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
E-screening & Brief Intervention (e-SBI)Feasibility: e-SBI Session 2 Completion RateCompleted e-SBI session 27 Participants
E-screening & Brief Intervention (e-SBI)Feasibility: e-SBI Session 2 Completion RateDid not complete e-SBI session 23 Participants
ControlFeasibility: e-SBI Session 2 Completion RateCompleted e-SBI session 24 Participants
ControlFeasibility: e-SBI Session 2 Completion RateDid not complete e-SBI session 20 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026